GlassScriptPhysician profile
Michele Hakimian
NPI 1164503967
$17,363.17
in general payments reported to CMS, 2019-2025
17 companies · $334 in 2025
The $334 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $248 · 2020: $92.34 · 2021: $10K · 2022: $1,696 · 2023: $4,582 · 2024: $171 · 2025: $334.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,360 · Food and Beverage: $727.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,360.26 |
| Food and Beverage | $727.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $11,877.42 | 2021-2022 | |
| Abbvie INC. | $4,405.67 | 2023-2024 | |
| Hologic Sales and Service, LLC | $411.13 | 2019-2025 | Myosure Tissue Removal Device, Novasure, Acessa Provu System |
| Aspira Women'S Health INC | $127.60 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $101.02 | 2019-2025 | |
| Avion Pharmaceuticals | $74.57 | 2020-2023 | Balcoltra |
| Coopersurgical, INC. | $70.79 | 2019-2025 | Paragard T 380a, Paragard T 380a |
| Astellas Pharma US INC | $68.21 | 2023-2025 | Veozah |
| Novo Nordisk INC | $40.59 | 2023-2024 | Wegovy |
| Therapeuticsmd, INC. | $37.18 | 2019 | |
| Myriad Women'S Health, INC. | $28.30 | 2023 | Myrisk |
| Exact Sciences Corporation | $26.41 | 2025 | The Cologuard Plus Collection Kit |
| Mayne Pharma Commercial LLC | $23.60 | 2025 | |
| Agile Therapeutics, INC. | $19.23 | 2023 | Twirla |
| Scynexis, INC. | $18.85 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lupin INC. | $16.52 | 2019 | |
| Amag Pharmaceuticals, INC. | $16.08 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michele Hakimian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.